Exosomes in Skincare: Plant-Derived vs Human-Derived and What the Science Shows

Exosomes have become one of skincare’s most talked-about ingredients. The appeal is easy to understand: tiny particles associated with cell communication sound like an exciting route to smoother, fresher-looking skin.

But exosome skincare covers different sources, preparations, and finished formulas. A botanical serum and a human cell-derived preparation may share a marketing keyword while having different compositions and supporting research.

Before choosing either, it helps to understand what scientists are studying and how those findings relate to your daily routine.

Exosomes are a specific type of extracellular vesicle, or EV: microscopic particles surrounded by a lipid membrane that cells release. These particles can carry proteins, lipids, and genetic material involved in biological communication.

However, scientists do not call every small vesicle an exosome. International research guidelines recommend using the broader term “extracellular vesicles” unless a particular cellular origin has been demonstrated. Consequently, an “exosome” claim on packaging deserves closer examination of the ingredient and its characterization.

Plant-derived vesicles come from botanical sources. One example being investigated for skincare is Centella asiatica, commonly called Cica.

A 2025 pilot study evaluated a Cica EV-containing serum in 20 people who applied it twice daily for 28 days. Researchers reported improvements in measured skin hydration, elasticity, and other skin-quality indicators.

Those findings are encouraging, but the study had important limitations. A separate comparison group of 10 people was added after the initial trial. It was neither randomized nor blinded, making the evidence less conclusive than a larger trial with participants assigned to treatment and placebo groups from the outset.

The practical takeaway is that a specific botanical EV formula showed promise. That does not establish the same benefits for every product marketed as plant-derived exosome skincare.

Human-derived preparations may be collected from cultured human cells. One studied source is human adipose tissue-derived stem cells. The vesicles are distinct from the living cells that produce them.

In a 12-week randomized clinical study, 28 participants received an exosome-containing solution with microneedling on one side of the face and saline with microneedling on the other. Researchers observed greater improvements in wrinkles, elasticity, hydration, and pigmentation measurements on the side receiving the exosome-containing solution.

Crucially, this was a combined professional treatment. The solution also contained other ingredients, including peptides and amino acids. The results therefore cannot establish that an everyday exosome cream applied to intact skin would produce the same effects, or that vesicles alone caused every improvement.

These studies do not establish a winner. They evaluated different preparations, application methods, participants, and treatment periods.

Plant-derived ingredients may appeal to shoppers who prefer botanical sourcing. Human-derived ingredients raise different questions about sourcing and processing. Neither origin, by itself, demonstrates superior performance or suitability for sensitive skin.

Our reading of the evidence is straightforward: the finished formula and the quality of its testing matter more than the source category alone. Comparing headline results from unrelated studies would give a misleading impression of which option works better.

Start with clear ingredient information. Does the description identify the source? Does it explain whether the ingredient consists of characterized vesicles, a broader cell-derived preparation, or a system inspired by vesicle technology?

A botanical extract, cell-conditioned medium, or synthetic delivery system should not automatically be treated as equivalent to a characterized EV preparation.

Next, examine the evidence behind the claim. Testing on the actual finished product is more relevant to your purchase than a laboratory experiment on a different ingredient. Vesicle identification, preparation methods, storage, and stability are also important considerations in EV research.

For readers interested in exploring this category, the COCOJOJO Exosome + Multi Peptide Encapsulated Cream is listed with an Exosome Complex alongside Copper Tripeptide-1, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7, and Acetyl Hexapeptide-8.

Consider the complete ingredient profile, cosmetic-use directions, and how the cream fits your existing routine. Its product name should not be interpreted as evidence that it uses the same preparation studied in a published trial.

If dryness is your main concern, you can also explore the COCOJOJO dryness and dehydration collection to compare formulas around that specific need.

Treat a topical cosmetic as an optional addition to a consistent routine. Follow its label directions, introduce one new product at a time, and test a small area first. Stop using it if irritation develops.

Keep cleansing, moisturizing, and daily sun protection central to your routine. For help organizing those steps, read The Glow Code: How to Build a Skincare Routine That Actually Works.

Professional procedures require a separate assessment. A retail cosmetic should not be assumed suitable for injection or application through freshly needled skin. The FDA states that there are currently no FDA-approved exosome products; cosmetic availability does not establish approval for medical treatment.

Exosomes represent an interesting area of skincare research, with encouraging early findings for both botanical and human cell-derived preparations. Their promise is worth following, while their differences deserve careful attention.

Choose according to transparent ingredient information, relevant testing, and your skin’s everyday needs. When exploring COCOJOJO skincare, let the complete formula guide your decision, and give a consistent routine more weight than a trending ingredient name.